The Indian Patent Office is presently considering a proposal that would make it mandatory for drug firms to disclose the WHO-assigned INN (International Non-proprietary names) in the pharma patent applications. This proposal has been mooted, according to the Patent Office, as it would help ensure that frivolous patents, which do not provide any enhancement of efficacy of a therapy, are not granted. In order to contextualise this proposal better, the working of an INN needs to be understood. An INN...
↧